DRREDDY (DRREDDY) Share Price
DRREDDY · M.Cap ₹1,14,563 CrDRREDDY trades at 41.51x TTM P/E (vs Pharma & Health sector median of 31.4x) with a 14.7% operating margin and ₹2,760 Cr annual net profit.
DRREDDY Share Price Chart & Multi-Horizon Returns
DRREDDY · 3M Price Action & VolumeSession Reference & Price Bands
NSE / BSE CashRange Positioning
Spot ₹1,373.00Market Depth & Order Flow (DRREDDY)
Combined NSE + BSE Order Book · 5-Level Bid/Ask Microstructure
| Bid Price | Exch | Orders | Qty |
|---|---|---|---|
| 0.00 | NSE | 0 | 0 |
| 0.00 | NSE | 0 | 0 |
| 0.00 | NSE | 0 | 0 |
| 0.00 | NSE | 0 | 0 |
| 0.00 | NSE | 0 | 0 |
| Ask Price | Exch | Orders | Qty |
|---|---|---|---|
| ₹1,373.00 | NSE | 6 | 423 |
DRREDDY (DRREDDY) Consolidated Profit & Loss Statement
Annual Financial Performance (Figures in ₹ Crore)
| Line Item (₹ Cr) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue / Sales | 21,545 | 24,670 | 28,011 | 32,644 | 33,700 | 33,097 |
| Operating Expenses | 17,778 | 18,200 | 20,078 | 24,097 | 27,247 | 28,245 |
| Operating Profit (EBIT/EBITDA) | 3,768 | 6,470 | 7,933 | 8,547 | 6,454 | 4,853 |
| Other Income | 555 | 971 | 909 | 1,119 | 1,372 | 1,263 |
| Interest & Depreciation | 1,261 | 1,393 | 1,641 | 1,987 | 2,433 | 2,591 |
| Profit Before Tax (PBT) | 3,061 |
Multi-Factor Quant Scores & Investment Thesis (DRREDDY)
Grounded Factor Decomposition & Institutional Bull vs. Bear Debate
RSI 81.7 · SMA20 ₹1,295.34
PAT ₹2,760 Cr · OPM 14.7%
Support ₹1,360.00 · Max Pain ₹1,340.00
Promoter 26.6% · FII+DII 52.2%
- Strong Put OI Floor at ₹1,360.00: Put writers have accumulated 7,81,875 OI at the ₹1,360.00 strike, acting as an institutional demand zone.
- Resilient Operating Cash & TTM PAT of ₹2,760 Cr: DRREDDY generated ₹4,853 Cr operating profit on ₹33,097 Cr revenue (14.7% operating margin).
- High Institutional & Promoter Skin-in-the-Game (78.8%): Promoters hold 26.63%, complemented by 20.30% FII and 31.87% DII holdings as of Sep 2026.
Pharma & Health Peer Comparison
Benchmarked by Market Cap, P/E, P/B, Dividend Yield & 1M Returns
| Company | Price (₹) | M.Cap (Cr) | P/E (x) | P/B (x) | Div Yld % | 1M Return |
|---|---|---|---|---|---|---|
| DRREDDY Ltd. | 1,373.00 | 1,14,563 | 41.51 | 2.95 | 0.62% | +16.36% |
| Sun Pharmaceutical Industries Ltd | 1,864.30 | 4,47,310 | 42.60 | 6.95 | 0.72% | +5.10% |
| Cipla Ltd | 1,562.00 | 1,26,110 | 29.40 | 4.62 | 0.83% | +3.40% |
DRREDDY Options Chain & OI Analytics
Active Expiry: 2026-11-23 · Spot ₹1,373.00 · Max Pain ₹1,340.00
| Call OI | Call LTP | Strike (₹) | Put LTP | Put OI |
|---|---|---|---|---|
| 2.31L | ₹46.30 | 1340.00 | ₹12.55 | 4.87L |
| 3.75L | ₹39.70 | 1350.00 | ₹15.40 | 6.66L |
| 4.72L | ₹33.10 | 1360.00 | ₹18.75 | 7.82L (Floor) |
| 10.84L | ₹26.85 | 1370.00 (ATM) | ₹22.60 | 4.11L |
| 11.41L (Wall) | ₹21.80 | 1380.00 | ₹27.45 | 4.57L |
| 1.69L | ₹17.30 | 1390.00 | ₹32.75 | 0.79L |
- Resistance wall is stronger: Call OI resistance is more concentrated than put OI support.
- Balanced options positioning: Current PCR and OI wall evidence is balanced, so options positioning is not strongly directional.
DRREDDY Latest News & Exchange Filings
Curated Market Updates, Announcements & Sentiment
Bafna Pharmaceuticals Limited
Board Meeting Intimation |Meeting Date: 11-Nov-2026
Aarey Drugs & Pharmaceuticals Limited
Board Meeting Intimation |Meeting Date: 14-Nov-2026
Vaishali Pharma Limited
Board Meeting Intimation |Meeting Date: 14-Nov-2026
Anuh Pharma Limited
Anuh Pharma Limited has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation